Copper and l -sodium ascorbate catalyzed hydroxylation and aryloxylation of aryl halides
摘要:
CuSO4 center dot 5H(2)O and NaAsc catalyzed hydroxylation and C-O/C-S cross-coupling reactions of aryl halides with phenols or 4-methylbenzenethiol were described. A wide range of substrates and test cases highlight the synthetic utility of the approach. A series of phenols, diaryl ethers, allcylaryl ethers, and diaryl thioethers were synthesized in high yield. (C) 2015 Elsevier Ltd. All rights reserved.
[EN] HYDANTOIN CONTAINING DEOXYURIDINE TRIPHOSPHATASE INHIBITORS<br/>[FR] HYDANTOÏNE CONTENANT DES INHIBITEURS DE LA DÉSOXYURIDINE TRIPHOSPHATASE
申请人:CV6 THERAPEUTICS (NI) LTD
公开号:WO2017006282A1
公开(公告)日:2017-01-12
Provided herein are dUTPase inhibitors, compositions comprising such compounds and methods of using such compounds and compositions.
提供的是dUTPase抑制剂,包括这样的化合物以及使用这些化合物和组合物的方法。
[EN] HETEROCYCLIC CHROMENE-SPIROCYCLIC PIPERIDINE AMIDES AS MODULATORS OF ION CHANNELS<br/>[FR] AMIDES DE CHROMÈNE HÉTÉROCYCLIQUE-PIPÉRIDINE SPIROCYCLIQUE UTILES COMME MODULATEURS DES CANAUX IONIQUES
申请人:VERTEX PHARMA
公开号:WO2011140425A1
公开(公告)日:2011-11-10
The invention relates to heterocyclic chromene-spirocyclic piperidine amides useful as inhibitors of ion channels. The invention also provides pharmaceutically acceptable compositions comprising the compounds of the invention and methods of using the compositions in the treatment of various disorders.
Compounds are provided that are modulators of the C5a receptor. The compounds are substituted piperidines and are useful in pharmaceutical compositions, methods for the treatment of diseases and disorders involving the pathologic activation of C5a receptors.